Tissue architecture techniques like 3D bioprinting and decellularized organs are shown, along with engineered tissues ready for implantation. The process also involves bioreactors, growth factors, ...

The adipose tissue, which serves as an endocrine organ ... which is a combination of 1% adipose-derived decellularized extracellular matrix and 0.5% alginate. This hybrid bioink limited the ...

Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that on December 19, 2024, it received recommendation letters from the US ...